Cancer at its most basic is the corruption of normal biological programs that control cell proliferation, metabolism, death, motility, stickiness and immune functions.
The Stojdl lab worked on harnessing the natural world of viruses to fight cancer. We designed and developed programmable replicating viruses called “oncolytic viruses” as biotherapies that directly target cancer cells and activate a patient's own immune system against their tumour.
The Stojdl Lab has now moved from working in an academic space to an industrial one. This gives us a strong translational platform to get our oncolytic immunotherapies to the cancer patients who need them. Visit www.turnstonebio.com to track our progress.
Huge thanks to all the individuals and groups who have funded our research for many years. Without their support, we would not be in a position to move our virus treatments into the clinic.